2025 Fall Conference | Industry Therapeutic Update from Harmony Biosciences: Explore WAKIX® (pitolisant) as a Treatment Option for Your Patients

Date Saturday 11/08/25

Time 12:00 PM - 01:00 PM PDT Add To Calendar

Session Format This program will be presented in-person only

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Industry Therapeutic Update

Director(s) Gerard Meskill, MD

Topic(s) Autoimmune Neurology, General Neurology, Movement Disorders, Sleep

Learning Objectives Hear Gerard Meskill, MD, discuss how WAKIX is thought to work, review clinical study results, and share more information on prescribing.

This program is NOT accredited for continuing education by any organization. Additionally, Industry Therapeutic Updates program content and the views expressed herein are those of the presenting corporate entity and not of the AAN. These programs are not an official part of the 2025 Fall Conference education or scientific programs, nor are they endorsed by the AAN. The AAN cannot affirm claims pertaining to FDA off-label medication, research use of pre-FDA drugs, or other research information that might be discussed. Industry Therapeutic Updates are industry events.

CME Available No CME available

Program Materials

Event Timeline
12:00 PM - 01:00 PM PDT	Speaker	Industry Therapeutic Update from Harmony Biosciences: Explore WAKIX® (pitolisant) as a Treatment Option for Your Patients Gerard Meskill, MD

Faculty Disclosures
Gerard Meskill, MD	Dr. Meskill has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Axsome Therapeutics. Dr. Meskill has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jazz Pharmaeuticals. Dr. Meskill has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Harmony Biosciences. Dr. Meskill has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Harmony Biosciences. Dr. Meskill has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Avadel Pharmaceuticals. Dr. Meskill has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Axsome Therapeutics. Dr. Meskill has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for Jazz Pharmaceuticals. Dr. Meskill has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Harmony Biosciences. Dr. Meskill has received research support from Jazz Pharmaceuticals. Dr. Meskill has received research support from Avadel Pharmaceuticals. Dr. Meskill has received research support from Alkermes Pharmaceuticals.

��ɫ��

��ɫ��